AVDL

Avadel Pharmaceuticals

75 hedge funds and large institutions have $126M invested in Avadel Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding:

less ownership

Funds ownership:

33% less capital invested

Capital invested by funds: $189M → $126M (-$62.7M)

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$678K
Puts
$594K
Net Calls
Net Calls Change

Top Buyers

1 +$1.64M
2 +$991K
3 +$833K
4
Citadel Advisors
Citadel Advisors
Florida
+$793K
5
BC
Broadfin Capital
New York
+$613K

Top Sellers

1 -$13.4M
2 -$9.45M
3 -$6.54M
4
Morgan Stanley
Morgan Stanley
New York
-$3.98M
5
GTC
Ghost Tree Capital
New York
-$2.45M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$30.5M
2
$16.7M
3
$16.7M
4
$8.16M
5
$7.08M
6
$6.43M
7
$5.88M
8
$4.99M
9
$2.99M
10
$2.96M
11
$2.76M
12
$2.72M
13
$2.03M
14
$1.93M
15
$1.53M
16
$1.44M
17
$1.22M
18
$1.06M
19
$956K
20
$833K
21
$813K
22
$623K
23
$616K
24
$478K
25
$380K